A Study of Changes in Heart Function and Blood Flow in People Receiving Anesthesia

NCT ID: NCT05954832

Last Updated: 2025-06-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

250 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-07-13

Study Completion Date

2027-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to understand changes in heart function (how the heart pumps blood) and blood flow in people who receive general anesthesia during surgery. The researchers are particularly interested in the heart function and blood flow changes in people who experience low blood pressure (hypotension) after receiving anesthesia.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Anesthesia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Echocardiography

Patients participating in this study will undergo routine anesthetic and perioperative care with the addition of an echocardiography and Clearsight BP measurement.

Echocardiography

Intervention Type DIAGNOSTIC_TEST

Echocardiography and Clearsight BP measurements before, immediately after anesthesia induction and after intubation (for 20 min)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Echocardiography

Echocardiography and Clearsight BP measurements before, immediately after anesthesia induction and after intubation (for 20 min)

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult patients ≥ 18 years of age requiring general anesthesia for surgery
* Intubation required for anesthetic management / surgery
* Anticipated prep time before incision of 20 minutes
* Baseline MAP \>70mmHg

Exclusion Criteria

* History of coronary artery disease
* History of cardiac disease (e.g., HTN, arrythmias, valvular and structural abnormalities)
* History of peripheral artery occlusive disease
* Beta-blocker use
* Anti-hypertensive medication use
* Patients with epidural, spinal, paravertebral, serratus blocks preoperatively
* Patients requiring rapid sequence induction (where intubation occurs concurrently with induction)
* Emergency surgery
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Memorial Sloan Kettering Cancer Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Anahita Dabo-Trubelja, MD

Role: PRINCIPAL_INVESTIGATOR

Memorial Sloan Kettering Cancer Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Memorial Sloan Kettering Cancer Center (All protocol activites)

New York, New York, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Anahita Dabo-Trubelja, MD

Role: CONTACT

212-639-3279

Gregory Fischer, MD

Role: CONTACT

212-639-2581

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Anahita Dabo-Trubelja, MD

Role: primary

212-639-3279

Related Links

Access external resources that provide additional context or updates about the study.

http://www.mskcc.org/mskcc/html/44.cfm

Memorial Sloan Kettering Cancer Center

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

23-079

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.